Björn Dahlöf - Publications, H-index & Citations

Björn Dahlöf

herlev & gentofte hospital

57H指数

249论文数

2.5W被引数

收录论文 85

发表时间

CS585, a novel prostacyclin receptor agonist, demonstrates sustained efficacy in vivo in the prevention of thrombosis

EUROPEAN HEART JOURNAL

IF35.6

2024-10-28

PREAI

Stanger, L.; Rickenberg, A.; Flores, M.; Dahlof, B.; Holinstat, M.

The Eicosanoid Analogue Cs585 Represents A First-in-class In Prevention Of Platelet Activation And Thrombosis Through Direct Activation Of The Prostacyclin Receptor

ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY

IF7.4

2023-05-01

PREAI

Yamaguchi, Adriana; Lambert, Sylviane; Stanger, Livia; Yalavarthi, Pooja; Rickenberg, Andrew; White, Andrew; Dahlof, Bjorn; Holinstat, Michael A.

Cardiovascular Benefits of Angiotensin-Converting Enzyme Inhibition Plus Calcium Channel Blockade in Patients Achieving Tight Blood Pressure Control and With Resistant Hypertension

AMERICAN JOURNAL OF HYPERTENSION

IF3.1

2020-11-20

OAAI

Brook, Robert D.; Kaciroti, Niko; Bakris, George; Dahlof, Bjorn; Pitt, Bertrtam; Velazquez, Eric; Weber, Michael A.; Jamerson, Kenneth A.

Prior Medications and the Cardiovascular Benefits From Combination Angiotensin-Converting Enzyme Inhibition Plus Calcium Channel Blockade Among High-Risk Hypertensive Patients

JOURNAL OF THE AMERICAN HEART ASSOCIATION

IF5.3

2018-01-09

OAAI

Brook, Robert D.; Kaciroti, Niko; Bakris, George; Dahlof, Bjorn; Pitt, Bertram; Velazquez, Eric; Weber, Michael; Zappe, Dion H.; Hau, Tsushung; Jamerson, Kenneth A.

THE TRUE INCIDENCE OF STATIN -RELATED ADVERSE EVENTS IN HYPERTENSIVE PATIENTS REVEALED BY COMPARISON OF BLINDED AND UN-BLINDED USE OF STATIN IN THE ANGLO-SCANDINAVIAN CARDIAC OUTCOMES TRIAL (ASCOT)

JOURNAL OF HYPERTENSION

IF4.1

2016-09-01

OAAI

Sever, Peter; Gupta, Ajay; Thompson, David; Whitehouse, Andrew; Collier, Tim; Dahlof, Bjorn; Poulter, Neil

Left Ventricular Wall Stress-Mass-Heart Rate Product and Cardiovascular Events in Treated Hypertensive Patients LIFE Study

HYPERTENSION

IF8.2

2015-11-01

OAAI

Devereux, Richard B.; Bang, Casper N.; Roman, Mary J.; Palmieri, Vittorio; Boman, Kurt; Gerdts, Eva; Nieminen, Markku S.; Papademetriou, Vasilios; Wachtell, Kristian; Hille, Darcy A.; Dahlof, Bjorn

Effect of Lower On-Treatment Systolic Blood Pressure on the Risk of Atrial Fibrillation in Hypertensive Patients 降低治疗中收缩压对高血压患者心房颤动风险的影响

HYPERTENSION

IF8.2

2015-08-01

OAAI

Okin, Peter M.; Hille, Darcy A.; Larstorp, Anne Cecilie K.; Wachtell, Kristian; Kjeldsen, Sverre E.; Dahlof, Bjorn; Devereux, Richard B.

Prevention of diabetic nephropathy by compound 21, selective agonist of angiotensin type 2 receptors, in Zucker diabetic fatty rats

AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY

IF3.4

2014-11-15

PREAI

Castoldi, Giovanna; di Gioia, Cira R. T.; Bombardi, Camila; Maestroni, Silvia; Carletti, Raffaella; Steckelings, U. Muscha; Dahloef, Bjorn; Unger, Thomas; Zerbini, Gianpaolo; Stella, Andrea

Direct angiotensin type 2 receptor (AT2R) stimulation attenuates T-cell and microglia activation and prevents demyelination in experimental autoimmune encephalomyelitis in mice

CLINICAL SCIENCE

IF7.7

2014-09-05

PREAI

Valero-Esquitino, Veronica; Lucht, Kristin; Namsolleck, Pawel; Monnet-Tschudi, Florianne; Stubbe, Tobias; Lucht, Franziska; Liu, Meng; Ebner, Friederike; Brandt, Christine; Danyel, Leon A.; Villela, Daniel C.; Paulis, Ludovit; Thoene-Reineke, Christa; Dahloef, Bjoern; Hallberg, Anders; Unger, Thomas; Sumners, Colin; Steckelings, U. Muscha

Angiotensin Type 2 Receptor Stimulation Ameliorates Left Ventricular Fibrosis and Dysfunction via Regulation of Tissue Inhibitor of Matrix Metalloproteinase 1/Matrix Metalloproteinase 9 Axis and Transforming Growth Factor β1 in the Rat Heart

HYPERTENSION

IF8.2

2014-03-01

OAAI

Lauer, Dilyara; Slavic, Svetlana; Sommerfeld, Manuela; Thoene-Reineke, Christa; Sharkovska, Yuliya; Hallberg, Anders; Dahlof, Bjorn; Kintscher, Ulrich; Unger, Thomas; Steckelings, Ulrike Muscha; Kaschina, Elena

Racial Differences in Incident Atrial Fibrillation Among Hypertensive Patients During Antihypertensive Therapy

AMERICAN JOURNAL OF HYPERTENSION

IF3.1

2014-02-19

OAAI

Okin, Peter M.; Bang, Casper N.; Wachtell, Kristian; Hille, Darcy A.; Kjeldsen, Sverre E.; Julius, Stevo; Dahlof, Bjorn; Devereux, Richard B.

Serial assessment of the electrocardiographic strain pattern for prediction of new-onset heart failure during antihypertensive treatment: the LIFE study

EUROPEAN JOURNAL OF HEART FAILURE

IF10.8

2014-02-18

OAAI

Okin, Peter M.; Oikarinen, Lasse; Viitasalo, Matti; Toivonen, Lauri; Kjeldsen, Sverre E.; Nieminen, Markku S.; Edelman, Jonathan M.; Dahlof, Bjorn; Devereux, Richard B.

In-treatment HDL cholesterol levels and development of new diabetes mellitus in hypertensive patients: The LIFE Study

DIABETIC MEDICINE

IF3.4

2013-05-24

OAAI

Okin, P. M.; Hille, D. A.; Wiik, B. P.; Kjeldsen, S. E.; Lindholm, L. H.; Dahlof, B.; Devereux, R. B.

Relationship of Sudden Cardiac Death to New-Onset Atrial Fibrillation in Hypertensive Patients With Left Ventricular Hypertrophy

CIRCULATION-ARRHYTHMIA AND ELECTROPHYSIOLOGY

IF9.8

2013-04-01

OAAI

Okin, Peter M.; Bang, Casper N.; Wachtell, Kristian; Hille, Darcy A.; Kjeldsen, Sverre E.; Dahloef, Bjoern; Devereux, Richard B.

AT2-receptor stimulation enhances axonal plasticity after spinal cord injury by upregulating BDNF expression

NEUROBIOLOGY OF DISEASE

IF5.6

2013-03-01

PREAI

Namsolleck, Pawel; Boato, Francesco; Schwengel, Katja; Paulis, Ludovit; Matho, Katherine S.; Geurts, Nathalie; Thoene-Reineke, Christa; Lucht, Kristin; Seidel, Kerstin; Hallberg, Anders; Dahlof, Bjorn; Unger, Thomas; Hendrix, Sven; Steckelings, U. Muscha

Mitral Annular Calcification and Incident Ischemic Stroke in Treated Hypertensive Patients: The LIFE study 接受治疗的高血压患者的二尖瓣环钙化和缺血性卒中: LIFE研究

AMERICAN JOURNAL OF HYPERTENSION

IF3.1

2013-02-07

OAAI

De Marco, Marina; Gerdts, Eva; Casalnuovo, Giuseppina; Migliore, Teresa; Wachtell, Kristian; Boman, Kurt; Dahlof, Bjorn; Olsen, Michael H.; Kizer, Jorge R.; Devereux, Richard B.; de Simone, Giovanni

Effects of body size and hypertension treatments on cardiovascular event rates: subanalysis of the ACCOMPLISH randomised controlled trial

LANCET

IF88.5

2013-02-01

PREAI

Weber, Michael A.; Jamerson, Kenneth; Bakris, George L.; Weir, Matthew R.; Zappe, Dion; Zhang, Ying; Dahlof, Bjorn; Velazquez, Eric J.; Pitt, Bertram

Effects of valsartan on morbidity and mortality in uncontrolled hypertensive patients with high cardiovascular risks: KYOTO HEART Study (Retraction of vol 30, pg 2461, 2009)

EUROPEAN HEART JOURNAL

IF35.6

2013-02-01

OAAI

Sawada, Takahisa; Yamada, Hiroyuki; Dahlof, Bjorn; Matsubara, Hiroaki

Impact of overweight and obesity on cardiac benefit of antihypertensive treatment

NUTRITION METABOLISM AND CARDIOVASCULAR DISEASES

IF3.7

2013-02-01

PREAI

Gerdts, E.; de Simone, G.; Lund, B. P.; Okin, P. M.; Wachtell, K.; Boman, K.; Nieminen, M. S.; Dahlof, B.; Devereux, R. B.

NeuroThera® Efficacy and Safety Trial-3 (NEST-3): a double-blind, randomized, sham-controlled, parallel group, multicenter, pivotal study to assess the safety and efficacy of transcranial laser therapy with the NeuroThera® Laser System for the treatment of acute ischemic stroke within 24 h of stroke onset

INTERNATIONAL JOURNAL OF STROKE

IF8.7

2012-09-27

PREAI

Zivin, J. A.; Sehra, R.; Shoshoo, A.; Albers, G. W.; Bornstein, N. M.; Dahlof, B.; Kasner, S. E.; Howard, G.; Shuaib, A.; Streeter, J.; Richieri, S. P.; Hacke, W.

研究方向